Ivermectin vs. lindane in the treatment of scabies.

Mohamad Goldust*, Elham Rezaee, Ramin Raghifar, Mohammad Naghavi-Behzad

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Scabies is commonly treated with acaricides but the treatment of choice is still controversial. This study aimed at comparing the efficacy of oral ivermectin vs. lindane lotion 1% for the treatment of scabies. Four hundred fourty patients with scabies were enrolled, and randomized into two groups: the first group received a single dose of oral ivermectin 200 microg/kg body weight, and the second group were treated with two applications of topical lindane lotion 1%, with a 1-week interval. Treatment was evaluated at intervals of 2 and 4 weeks, and if there was treatment failure at the 2-week follow-up, treatment was repeated. Single dose of oral ivermectin provided a cure rate of 63.6% at the 2-week follow-up, which increased to 81.8% at the 4-week follow-up after repeating the treatment. Treatment with two applications of lindane lotion 1%, with a 1-week interval between them, was effective in 45.4% of patients at the 2-week follow-up, which increased to 63.6% at the 4-week follow-up after this treatment was repeated. Single dose ivermectin was as effective as two applications of lindane lotion 1% at the 2-week follow-up. After repeating the treatment, ivermectin was superior to lindane lotion 1% at the 4-week follow up.

OriginalsprogEngelsk
TidsskriftAnnals of Parasitology
Vol/bind59
Udgave nummer1
Sider (fra-til)37-41
Antal sider5
ISSN2299-0631
StatusUdgivet - 1. jan. 2013

Fingeraftryk Dyk ned i forskningsemnerne om 'Ivermectin vs. lindane in the treatment of scabies.'. Sammen danner de et unikt fingeraftryk.

Citationsformater